Eucrates Biomedical Acquisition - Warrants (23/10/2027) Overview

Eucrates Biomedical Acquisition - Warrants (23/10/2027) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for EUCRW.

Quarterly EBIT

-$263.19K

↑ 46.65% YoY

As of Dec 31, 2022

Annual EBIT (TTM)

-$698.58K

↑ 30.35% YoY

Trailing 12 months ending Dec 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin